{"nct_id":"NCT00527826","title":"Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV","status":"COMPLETED","status_verified_date":"2012-10","start_date":"2007-11","start_date_type":null,"primary_completion_date":"2009-07","primary_completion_date_type":"ACTUAL","completion_date":"2009-07","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}